Background and Aims
EUS-guided fine needle biopsy (FNB) sampling and FNA are important methods for obtaining
core tissues and cytologic aspirates. To improve the specimen quality for pathologic
evaluation, a novel EUS-FNB Shark Core (SC) needle has been designed to acquire core
tissue during EUS procedures. We compared the histology yield of EUS-FNB sampling
using the SC needle (EUS-FNB-SC) to EUS-FNA in patients who had solid pancreatic and
nonpancreatic lesions.
Methods
This was a retrospective case-control study design. Between July 2012 and July 2015
all patients who had EUS-FNB-SC and EUS-FNA were reviewed through a hospital EUS database.
Consecutive samples from EUS-FNB-SCs were matched in a 1:3 ratio by lesion site (eg,
pancreatic head) and needle gauge (ie, 19 gauge, 22 gauge, 25 gauge) to recent random
samples of EUS-FNA. The procedures were performed with rapid onsite evaluation. For
study purposes specimen slides were evaluated by 2 cytopathologists for histologic
yield using a standard scoring system (0 = no material, 1-2 = cytologic, 3-5 = histologic).
The main objectives were to assess the histologic yield of the samples and compare
the median number of passes required to obtain core tissue by using EUS-FNB-SC and
EUS-FNA needles.
Results
Of the 156 patients included in study, 25% patients (n = 39) were in the EUS-FNB-SC
group and 75% (n = 117) in the EUS-FNA group. According to standard scoring criteria
for histology, the median histology score for EUS-FNA was 2 (sufficient for cytology
but not histology) and for EUS-FNB-SC was 4 (sufficient for adequate histology). Ninety-five
percent of the specimens obtained from the EUS-FNB-SC group were of sufficient size
for histologic screening, compared with 59% from the EUS-FNA group (P = .01). The median number of passes required to achieve a sample was significantly
lower in the EUS-FNB-SC group compared with the EUS-FNA group (2 passes vs 4 passes,
P = .001). There was significant difference in the median number of passes to all lesion
sites and needle gauges.
Conclusions
The histology yield was significantly higher using the EUS-FNB-SC needle compared
with the EUS-FNA needle. Additionally, fewer passes were required to obtain histology
cores when using EUS-FNB-SC.
Abbreviations:
EUS-FNA (EUS-guided FNA), EUS-FNB (EUS-guided fine needle biopsy), EUS-TNB (EUS-guided Tru-Cut needle biopsy), EUS-FNB-SC (EUS-guided fine needle biopsy sampling using the Shark Core needle), ROSE (rapid onsite cytologic evaluation)To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Gastrointestinal EndoscopyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- EUS for detection of the hepatocellular carcinoma: results of a prospective study.Gastrointest Endosc. 2007; 66: 265-273
- Endoscopic ultrasound-guided fine-needle aspiration biopsy for lymphadenopathy of unknown origin.Endoscopy. 2006; 38: 919-924
- Endoscopic ultrasound-guided fine-needle aspiration of left adrenal gland masses.Endoscopy. 2007; 39: 65-71
- Role of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for diagnosis of solid pancreatic masses.Dig Endosc. 2011; 23: 29-33
- EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis.Gastrointest Endosc. 2012; 75: 319-331
- Current status of diagnostic endoscopic ultrasonography in the evaluation of pancreatic mass lesions.Dig Endosc. 2011; 23: 17-21
- Influence of on-site cytopathology evaluation on the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of solid pancreatic masses.Am J Gastroenterol. 2011; 106: 1705-1710
- Yields and utility of endoscopic ultrasonography-guided 19-gauge trucut biopsy versus 22-gauge fine needle aspiration for diagnosing gastric subepithelial tumors.Clin Endosc. 2015; 48: 152-157
- Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA.J Gastroenterol. 2009; 44: 742-750
- EUS-guided fine-needle aspiration combined with flow cytometry and immunocytochemistry in the diagnosis of lymphoma.Gastrointest Endosc. 2001; 53: 485-491
- EUS-guided tissue acquisition: an evidence-based approach (with videos).Gastrointest Endosc. 2014; 80: 939-959
- A meta-analysis comparing ProCore and standard fine-needle aspiration needles for endoscopic ultrasound-guided tissue acquisition.Endoscopy. 2016; 48: 339-349
- Randomized study comparing endoscopic ultrasound-guided Trucut biopsy and fine needle aspiration with high suction.Cytopathology. 2010; 21: 44-51
- Validation of a multidisciplinary infrastructure to capture adverse events in a high-volume endoscopy unit.Clin Gastroenterol Hepatol. 2015; 13: 221-227
- Comparison of EUS-guided 19-gauge Trucut needle biopsy with EUS-guided fine-needle aspiration.Endoscopy. 2004; 36: 397-401
- Rescue endoscopic ultrasound (EUS)-guided trucut biopsy following suboptimal EUS-guided fine needle aspiration for mediastinal lesions.Gut Liver. 2013; 7: 150-156
- Prospective study of a Trucut needle for performing EUS-guided biopsy with EUS-guided FNA rescue.Gastrointest Endosc. 2005; 62: 597-601
- Preliminary experience with an EUS-guided trucut biopsy needle compared with EUS-guided FNA.Gastrointest Endosc. 2003; 57: 101-106
- Endoscopic ultrasound-guided tissue sampling by combined fine needle aspiration and trucut needle biopsy: a prospective study.Cytopathology. 2006; 17: 27-33
- EUS-guided tissue sampling: comparison of “dual sampling” (Trucut biopsy plus FNA) with “sequential sampling” (Trucut biopsy and then FNA as required).Endoscopy. 2007; 39: 725-730
- 25-gauge histology needle versus 22-gauge cytology needle in endoscopic ultrasonography-guided sampling of pancreatic lesions and lymphadenopathy.Endosc Int Open. 2015; 3: E63-E68
- Core needle versus standard needle for endoscopic ultrasound-guided biopsy of solid pancreatic masses: a randomized crossover study.Endoscopy. 2014; 46: 1063-1070
- Mo1415 randomizied trial comparing 22 and 25 gauge core biopsy needles for EUS-FNA of solid pancreatic and peripancreatic mass.Gastrointest Endosc. 2014; 79 ([abstract]): AB428
- A multicenter prospective randomized controlled cross-over trial comparing endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA) and fine needle biopsy (FNB) for pancreatic and non-pancreatic masses.Gastrointest Endosc. 2014; 79 ([abstract]): AB188-AB189
- Tu1638 initial experience with a novel EUS-guided core biopsy needle (Sharkcore™): a North American multicenter study.Gastrointest Endosc. 2015; 81 ([abstract]): AB540-AB541
- EUS-guided Trucut needle biopsies as first-line diagnostic method for patients with intestinal or extraintestinal mass lesions.Surg Endosc. 2009; 23: 2351-2355
- Use of samples from endoscopic ultrasound–guided 19-gauge fine-needle aspiration in diagnosis of autoimmune pancreatitis.Clin Gastroenterol Hepatol. 2012; 10: 316-322
Article info
Publication history
Published online: March 23, 2016
Accepted:
March 16,
2016
Received:
January 6,
2016
Footnotes
DISCLOSURE: The following author disclosed financial relationships relevant to this publication: M. B. Wallace: Consultant for Olympus Corp.; grant support from Boston Scientific and Cosmo Pharmaceuticals. All other authors disclosed no financial relationships relevant to this publication.
Identification
Copyright
Copyright © 2016 by the American Society for Gastrointestinal Endoscopy